Company

CEL SCI CORP (CVM)

Standardized SEC financial data for CEL SCI CORP — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000725363 · NYSE · Biological Products, (No Diagnostic Substances).

Revenue growth (YoY)

-37.3%

Return on equity

-159.3%

ROIC

-151.2%

Free cash flow

-$17.2M

Debt / equity

0.50×

Current ratio

2.26×

EPS (diluted)

$-6.27

Ratios for fiscal year 2013, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
R&D expense	$17.8M	$23.1M	$25.4M	$22.5M	$18.2M	$15.9M
SG&A expense	$11.7M	$13.1M	$10.7M	$9.0M	$8.2M	$8.9M
Operating income	-$29.0M	-$36.2M	-$36.1M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$15.5M	$36.1M	$22.7M	$4.1M	$4.7M	$11.0M
Inventory	$820K	$2.0M	$2.0M	$2.2M	$1.0M	—
Total current assets	$17.7M	$45.3M	$25.4M	$6.9M	$6.1M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$15.3M	-$18.8M	-$18.2M	-$22.8M	-$18.8M	-$17.1M
Capital expenditures	$2.7M	$9.0M	$638K	$362K	$95K	$38K
Free cash flow	-$17.9M	-$27.8M	-$18.9M	-$23.2M

Get CVM data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CVM/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CVM/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View CVM filings on SEC EDGAR →